I n response to Ag, plasma cells develop from Ag-specific B lymphocytes, which peak 1 to 2 wk after Ag exposure. A secondary encounter with Ag can result in Abs of higher affinity and an increased and persistent serum level of specific Igs. Maintenance of Ab levels requires continuous secretion of Ig by plasma cells and protection from degradation. Of the five Ab classes, IgG is the most prevalent class in the serum and nonmucosal tissues and the only isotype that is actively transferred from mother to offspring, to confer short-term passive immunity. In 1958, Brambell (1) described a saturable receptor that mediates the transport of maternal IgG to the fetus; then, he inferred the presence of a similar or identical receptor that protected IgG from catabolism to make it the longest surviving of all plasma proteins (2) .
The neonatal FcR (FcRn) was first identified in the 1970s as the protein that mediates transfer of maternal, milk-borne IgGs across the rodent neonatal intestine (3) . Subsequently, FcRn was shown to comprise a heterodimer of two polypeptides that binds IgG in a strictly pH-dependent way, with binding occurring at slightly acidic pH and no detectable binding at pH 7.4 (4, 5) . Later it was shown that the functional FcRn is composed of an MHC class I-like a-chain and the b 2 -microglobulin (b 2 m) (6) . Since these initial studies, others have shown that FcRn plays a central role in regulating the transport of IgG within and across cells of diverse origin, and it also serves to rescue IgG from degradation, thereby prolonging its half-life throughout adult life (7) . The mechanism was originally thought to be mediated mainly by endothelial cells, which line blood vessels (8) . However, recent findings suggest that this process occurs also in hematopoietic cells (9, 10) , or even in mammary epithelial cells during lactation (11) .
It has long been known that elevated serum concentration of any IgG subclass is associated with shortened biologic half-life and increased fractional catabolic rate (12) . This is especially adverse in hyperimmunization; hence frequent immunization is required to maintain high levels of Ag-specific Abs (13) . However, the ability to overcome rapid IgG degradation by overexpressing the FcRn has not yet been investigated. Therefore, one of our goals was to analyze the effect of FcRn overexpression on the Ag-specific IgG response. We performed experiments employing the transgenic (Tg) mice we have recently created (14) , using a bacterial artificial chromosome (BAC) that contains the bovine FcRn (bFcRn) a-chain gene (bFCGRT). Two of the Tg lines showed copy numberrelated bFcRn expression and demonstrated a significantly extended half-life of mouse IgG (mIgG), indicating that bFcRn forms a functional complex with the mouse b 2 m and thus binds and protects mIgG (14) .
As more recent data indicated that FcRn fulfills a major role in IgG-mediated phagocytosis (15) and Ag presentation (16, 17) , we explored the possibility that FcRn overexpression might increase the humoral immune response via these mechanisms. Therefore, we immunized these animals with T-dependent (OVA, trinitrophenyl [TNP]-labeled human g-globulin and an influenza vaccine) and T-independent (FITC-dextran) Ags, using standard protocols, and analyzed various factors of the humoral immune response. Because FcRn protects not only IgG but also albumin from degradation (18) , we were also interested in and studied the effect of bFcRn overexpression on the serum albumin concentration before and after immunization.
The higher Ag-specific IgG level, in addition to the greater number of Ag-specific B cells and plasma cells we found in these Tg animals after immunization, recommends their use in polyclonal and mAb production.
Materials and Methods

Mice
Male 10-to 12-wk-old FVB/N (wild-type [wt] ) and bFcRn Tg mice were used. The generation and basic phenotype of the Tg mice have been recently published (14) . Briefly, a BAC containing the bovine FcRn a-chain gene (bFCGRT) with its 44-kb-long 59 and 50-kb-long 39 flanking sequences was microinjected into fertilized mouse oocytes. Two of the Tg lines generated (line no. 14 and no. 19) showed copy number-dependent bFcRn expression. In the current study, we used homozygous mice of line no. 14 and hemizygous mice of line no. 19 that carry four (FVB/N_Tg4) and five (FVB/N_Tg5) copies of the bFCGRT, respectively. FVB/N mice were obtained from the Charles River Laboratories Hungary (Budapest, Hungary). For TNP-huIgG and Fluval P vaccine immunizations, we used Tg mice on a BALB/c background, which was created by backcrossing line no. 19 to a BALB/c background. We used offspring of the ninth generation carrying five transgene copies (BALB/c_Tg5). All animals were kept in the conventional animal house of the Agricultural Biotechnology Center, Gödöllő, in compliance with Institutional Animal Care and Ethics Committeeapproved protocols.
Ags and immunizations
OVA, FITC-dextran, CFA, and IFA were purchased from Sigma-Aldrich (Budapest, Hungary). Human IgG (hIgG) and chicken IgY were purchased from Invitrogen (Carlsbad, CA) and Southern Biotechnology (Birmingham, AL), respectively. TNP human IgG (TNP-hIgG) and chicken IgY (TNP-IgY) were prepared by a modification of the method by Rittenberg and Amkraut (19) , in which various concentrations of trinitrobenzene sulfonic acid (Pierce Chemical, Rockford, IL) were reacted with a given amount of hIgG and IgY. TNP-hIgG was used for immunization at a conjugation ratio of 37 mol TNP/mol hIgG (TNP 37 -hIgG). TNP-IgY was used as a test Ag for determining anti-hapten Ab at conjugation ratios of 1.5, 4, and 42 mol TNP/mol IgY (TNP 1.5, 4, 42 -IgY). Fluval P vaccine, which is an inactivated split-virion preparation of virus strain A/California/07/2009 H1N1-like NYMC X-179A with aluminum phosphate adjuvant, was obtained from Omninvest (Hungary) (20) . Tg and wt mice (age-, strain-, and sex-matched; five in each group) were i.p. immunized with 250 mg OVA or 250 mg FITC-dextran in CFA and challenged 14 d later with 250 mg OVA or 250 mg FITC-dextran with IFA. Animals were i.p. immunized with 100 mg TNP-hIgG in CFA and challenged 14 and 28 d later with 100 mg TNP-hIgG with IFA. For Fluval P immunization, 170 ml vaccine suspension was injected i.p., and animals were challenged 21 d later with 100 ml vaccine.
ELISA measurements of the Ag-specific and total Ig levels High-binding ELISA plates (Costar 9018, Corning, NY) were coated with OVA, FITC-BSA, TNP-IgY (5 mg/ml each); 200-fold dilution of the monovalent form of inactivated A/California/7/2009 virus; or unlabeled goat anti-mouse polyclonal IgG (2 mg/ml) (H+L) (Southern Biotechnology Associates, Birmingham, AL) in 0.1 M sodium carbonate-bicarbonate buffer (pH 9.6) for 2 h at room temperature and then were washed with 0.1 M PBS (pH 7.2) containing 0.05% Tween 20 (PBS-Tween) and blocked with PBS containing 1% BSA for 1 h at room temperature. Serially diluted serum samples were added to the wells and incubated for 1 h at room temperature. Each plate included standard controls of serially diluted Agspecific immune sera. After washing, bound serum Ab was revealed by HRP-labeled goat anti-mouse IgM or IgG (1:4000-fold dilution, Southern Biotechnology Associates). The peroxidase-conjugated Abs were detected using tetramethylbenzidine (Sigma-Aldrich) as the substrate, and OD at 450 nm was measured with the Multiscan ELISA Plate Reader (Thermo EC). Serial dilutions of each test serum sample were applied, and Agspecific IgM and IgG titers as half-maximal values were determined by GraphPad Prism 5 nonlinear regression to the hyperbolic saturation function. For measurement of total IgG levels, standard curves were constructed using affinity purified mIgG (Sigma-Aldrich), and serum IgG concentrations were determined based on absorbance values at 450 nm interpolated from a linear portion of the standard curve. Samples were assayed in duplicates. At the peak of the OVA-specific immune response (day 44), sera were assayed for OVA-specific IgG isotypes. OVA as capture reagent and HRP-conjugated goat anti-mIgG1, IgG2a, IgG2b, and IgG3 (Southern Biotechnology Associates) as detecting reagents were used to evaluate the titers of anti-OVA IgG isotypes.
ELISPOT assays
MultiScreen HTS plates (Millipore, Bedford, MA) were coated with 100 mg/ml OVA, or with the 100-fold dilution of the monovalent form of inactivated A/California/7/2009 virus in PBS, at room temperature for 3 h. The plates were then washed with PBS and blocked with RPMI 1640 medium containing 5% FCS and mercaptoethanol (50 mM) for 30 min at room temperature. Serial dilutions (starting at 5 3 10 5 cells/well) of spleen lymphocytes were added to the wells. The plates were incubated at 37˚C with 5% CO 2 overnight and washed with PBS-Tween; HRP-conjugated goat anti-mouse IgM and IgG (1:4000-fold dilution; Southern Biotechnology Associates) was then added to each well. After 1 h incubation at room temperature, the plates were washed with PBS-Tween. The plates were then incubated in the presence of a chromogen substrate, 3-amino-9-ethylcarbazole (Sigma-Aldrich), and H 2 O 2 at room temperature, and the reaction was terminated by a water wash. The spots were counted in the ImmunoScan ELISPOT reader (Cellular Technology) and evaluated by ImmunoSpot software version 3.2 (Cellular Technology).
Virus neutralization assay
Serum Ab titers against the Fluval P vaccine virus strain (Influenza A/ California/07/09 HlN1) were measured by hemagglutination inhibition with chicken RBCs following standard procedures (21) . Briefly, sera were heat inactivated at 56˚C and serially diluted in 0.05 ml protein-free RPMI 1640. Virus (100 tissue culture infective doses in 0.05 ml/well) was then added to the plates containing test sera, and they were incubated at 37˚C for 1 h. After incubation, the virus-serum mixtures were transferred to Madin-Darby canine kidney monolayer plates, and the virus was allowed to adsorb for 18-24 h. The neutralization mixture was then aspirated; the plates were re-fed with 0.1 ml protein-free RPMI 1640 per well, containing 2 mg trypsin per milliliter, and incubated in 5% CO 2 at 34˚C for 5 d. Then, 0.025 ml 1% chicken erythrocytes in PBS was added per well. After 1-4 h at room temperature, absence of macroscopically visible hemagglutination in a well was interpreted as neutralization. At least two microtiter rows were run for each serum sample. Neutralization titers were calculated using the Karber method, with the dilution (in log2) giving 50% neutralization and expressed arithmetically as the reciprocal of the dilution.
Assays for relative affinities of anti-OVA and anti-TNP serum Abs
The relative affinity of anti-OVA serum Abs was compared using indirect competitive ELISA, based on the method of Friguet et al. (22) . Serum IgG was purified from the pooled sera at the peak of the OVA-specific immune response (day 44), using an agarose-immobilized protein G column (Pierce Chemical). Recovered IgG was adjusted to a fixed concentration (100 ng/ ml), which was deduced from the linear part of the ELISA curve obtained by OVA-ELISA. IgGs were preincubated with serial dilutions of OVA (from the concentration of 100 mg/ml to 0.01 mg/ml) in PBS-Tween for 2 h. Aliquots of these solution-phase equilibrium mixtures were transferred to OVA-coated plates (50 mg/ml OVA) and incubated for 1 h; the amount of free Abs was then determined as indicated above. Then logIC 50 values (23, 24) were calculated using GraphPad Prism 5 "One site-Fit logIC50 equation" algorithm.
The relative affinity of anti-TNP serum IgG was compared by calculating the TNP 4 -IgY/TNP 42 -IgY binding ratios based on the method of Herzenberg et al. (25) . Briefly, ELISA plates were coated with TNP 4 -IgY or TNP 42 -IgY (10 mg/ml) in coating buffer for 2 h at room temperature. After washing and blocking, serially diluted serum samples at the peak of the TNP-specific immune response (day 49) were added to the wells and incubated for 1 h at room temperature. TNP 4 -and TNP 42 -specific IgG titers were measured as described earlier and expressed as half-maximal values based on a nonlinear regression to the hyperbolic saturation function (26) .
Biosensor assay for the binding kinetics of anti-TNP serum IgG
The rate constants of anti-TNP serum IgG were determined by continuous-flow quartz crystal microbalance (QCM) technique using Attana A-100 equipment (Attana, Stockholm, Sweden). The on and off rate constants were directly assessed by a label-free biosensor experiment. In QCM, binding of a reactant to the immobilized macromolecule evokes a slowing of the crystal resonant frequency proportional to the bound mass. Monitoring the association and dissociation reactions thereby allows estimation of the on and off rate constants, as well as the concentration of the reacting macromolecule in the sample. The equilibrium binding constant of the immune complex (IC) can be calculated as the ratio of off to on rate constants.
TNP-IgY at a conjugation ratio of 1.5 mol TNP/mol IgY (TNP 1.5 -IgY) was immobilized onto a carboxyl sensor chip via amine coupling. Briefly, the carboxyl surface was activated by a 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide/N-hydroxysulfosuccinimide mixture according to the manufacturer's protocol. TNP 1.5 -IgY was immediately injected over the surface for 5 min at a concentration of 2 or 4 mg/ml, diluted in 10 mM Na acetate pH 4.7, followed by washing and blocking the remaining activated groups by the injection of 1 M ethanolamine. To examine nonspecific binding, underivatized IgY at a concentration of 10 mg/ml was immobilized onto a separate sensor chip with the same chemistry. Kinetic measurements were carried out in a running buffer of 10 mM HEPES, 150 mM NaCl, 0.005% Tween 20, pH 7.4, at a flow rate of 25 ml/min at 25˚C. The association and dissociation phases were monitored for 100 s and 300 s, respectively, at 12, 15, and 18 mg/ml final concentrations of anti-TNP IgG pools, which were collected before and 49 d after immunization and purified using agarose-bound protein G column. The preimmunized IgG samples exhibited marginal nonspecific binding. Regeneration of the surface was achieved by duplicate 30-s pulses of 10 mM glycine-HCl at pH 3.0. Sensorgrams were analyzed by Attester Evaluation software (v3.1.2, Attana), and the rate constants were estimated by ClampXP v3.50, using the one-site binding model.
Flow cytometry
Single-cell suspensions from spleen were isolated and first incubated with anti-CD32/CD16 (clone 2.4G2) for 30 min. Then the cells were incubated with fluorochrome-conjugated specific Abs at 4˚C for 50 min in staining buffer (PBS with 0.1% BSA and 0.1% sodium azide), washed twice, and then analyzed using a FACSCalibur equipped with CellQuest software (BD Biosciences, San Jose, CA). Anti-mouse CD45R/B220-PECy5, CD3-PE, IgM-FITC, and CD11b-A647 were obtained from eBioscience (San Diego, CA). Anti-mouse CD11c-PE, Gr-1(Ly-6G)-PE, and CD138-PE were purchased from BD Pharmingen (San Diego, CA). Isotype controls were obtained from BD Pharmingen or eBioscience.
Phagocytosis assay
For a neutrophil-enriched cell preparation, mice were injected i.p. with 1 ml of 1 mg/ml casein (Sigma-Aldrich) in sterile saline. The procedure was repeated 12 h later, and peritoneal cells were isolated 3 h after the second injection. Neutrophils were then further purified by Ficoll-Paque PLUS (GE Healthcare, Uppsala, Sweden) centrifugation (400 3 g for 30 min at room temperature). The purity of the neutrophils was ∼96%, as determined by flow cytometry using anti-CD11b and anti-Gr-1 reagents. Alexa 488 labeling of OVA was performed by the procedure described in the manufacturer's instructions (Molecular Probes, Eugene, OR). To produce Alexa 488-OVA-anti-OVA Ab complex, 1 mg Alexa 488-OVA (1 mg/ml) was preincubated at 37˚C for 60 min with 5 ml serum of OVA-immunized mice, and the complex was added to 5 3 10 5 purified neutrophil cells. Neutrophils were then further incubated at 37˚C, and after 30 min cells were put on ice, labeled with anti-Gr-1-PE, and analyzed by flow cytometry. Trypan blue was used for quenching, to discriminate between adherent and ingested particles.
bFcRn expression in neutrophil granulocytes
Total RNA from purified neutrophils was extracted using TRIzol Reagent (Invitrogen, Carlsbad, CA), and 2 ml of it was reverse transcribed with Moloney murine leukemia virus reverse transcriptase (Promega) and (dT) 17-adapter primer. PCR was performed to obtain a 548-bp-long bFcRn a-chain-specific amplicon (64-613 bp of AF139106) by the following primer pair: BORE10 59-CTG GGG CCG CAG AGG GAA GG-39 and BORE5 59-CTG CTG CGT CCA CTT GAT A-39, which was then separated by electrophoresis on 1% agarose gel and stained with ethidium bromide.
Analysis of serum albumin level
Serum albumin levels (five animals in each group) before and 56 d after OVA immunization (at the age of 56 d and 112 d, respectively) and nonimmunized animals at the age of 112 d were analyzed using a mouse albumin ELISA quantification kit (Bethyl Laboratories).
Chromosomal localization of the transgene
To visualize the genomic integration of the 128E04 transgene, fluorescence in situ hybridization (FISH) was performed. The 128E04 BAC DNA was labeled by nick-translation with biotin-14-29-deoxyadenosine triphosphate (BioNick DNA Labeling System; Invitrogen). Mitotic chromosomes were obtained from vinblastine-treated fibroblasts, which were isolated from 13.5-d-old homozygote no. 14 and no. 19 embryos, respectively, following standard protocols involving hypotonic treatment and methanol/acetic acid (3:1) fixation. FISH was performed essentially as published (27) . The biotinylated probe was denatured and allowed to hybridize with denatured chromosome spreads, overnight at 37˚C. Hybridization sites on chromosomes were amplified with an anti-biotin Ab raised in goat (Vector Laboratories, Burlingame, CA) and visualized by further incubation with fluorescein-conjugated rabbit anti-goat IgG (Nordic Immunological Laboratories, Tilburg, The Netherlands). Chromosome preparations were counterstained with DAPI (Vector Laboratories) and observed with a Nikon Eclipse E600 epifluorescence microscope (Nikon Instruments, Kawasaki, Japan). Fluorescence images were captured using a Cohu 4912 CCD camera (Cohu, San Diego, CA) and digitized with MacProbe 4.3 FISH software (Applied Imaging, Newcastle upon Tyne, U.K.) running on an Apple Macintosh G4 computer.
Statistics
Student's two-tailed t test and two-way ANOVA were used to evaluate the statistical significance of mean values of treatment groups. Values were considered to differ significantly if p , 0.05.
Results
Immunization with OVA resulted in a robust augmentation of the immune response in Tg mice
To investigate the consequences of bFcRn overexpression in Tg mice, first we immunized them with OVA. No difference between wt and Tg (FVB/N_Tg4 and FVB/N_Tg5) animals during the primary immune response was observed; however, after the booster immunization, the OVA-specific IgM and IgG titers showed a remarkable difference. Specifically, the IgM titers were significantly elevated during the secondary immune response (Fig. 1A) , whereas the IgG titers were nearly tripled in FVB/N_Tg4 and FVB/N_Tg5 mice, compared with the wt animals (Fig. 1B) . Then, we analyzed the quality of the OVA-specific IgGs from FVB/N_Tg4 and wt mice, comparing their OVA-binding capability, and observed no difference between them (Fig. 1C) . We found that the total IgG level rose steadily after immunization and reached peak levels on day 28 and 36 in wt and Tg animals, respectively. Notably, we found a remarkable and significant difference at the highest IgG levels, which were 14.8 6 2.6 mg/ml (mean 6 SEM) in wt versus 39.9 6 2.7 mg/ml and 39.3 6 2.2 mg/ml in FVB/N_Tg4 and FVB/ N_Tg5 mice, respectively (p , 0.001) (Fig. 1D) . The IgG subclass profile of OVA-specific serum Igs was determined on day 44 of immunization in wt and FVB/N_Tg4 mice. The Tg mice generated significantly higher OVA-specific IgG1, IgG2a, and IgG2b. Although Tg mice generated higher IgG3 compared with that of wt mice, the difference was not significant owing to a large SD. Animals in both groups produced predominantly IgG1 anti-OVA Abs, and we noted that IgG1 levels are much more strongly increased (∼10-fold) compared with those of IgG2a and IgG2b (∼2-to 3-fold) in these mice (Supplemental Fig. 1) .
We also observed that the increase of spleen size along with its cell number following immunization was more pronounced in FVB/N_Tg4 animals than in wt controls (p , 0.001) (Fig. 1E) . We also found multiple-fold increase of OVA-specific IgM and IgG producer cells (p , 0.001) in the spleen of FVB/N_Tg4 animals compared with their controls (Fig. 1F) . As a result, we concluded that FcRn overexpression promotes an augmented Ag-specific B cell clonal expansion during immunization.
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Immunization resulted in substantial differences in cell populations in the spleen between Tg and wt mice
To examine whether the elevated immune response and increased spleen size of the Tg animals were associated with changes in the cellular composition of the spleen, we immunized FVB/N_Tg4 and wt mice with OVA and characterized the cell populations in the spleen 3 d after the booster immunization (day 17) by flow cytometry. We observed a lower proportion of B (B220 + ) and T (CD3 + ) lymphocytes in Tg animals, compared with their wt controls; however, calculation of the total cell number revealed that their absolute numbers were higher in Tg animals ( Fig. 2A,  2B ). Immunization significantly increased the number of neutrophil granulocytes (Gr1 + /CD11b + ) in both groups, and this change was more radical in Tg animals (22-fold), compared with their controls (8-fold) (Fig. 2C) . The elevated number of granulocytes was reflected also in the proportionate increase of these cell types among splenocytes. These results explained the proportional decrease of cells bearing B220, and those that were CD3 + ( Fig. 2A,  2B) . We also observed that many more dendritic cells (CD11b + / CD11c + ) were present in Tg mice (Fig. 2D) 2 ) were also doubled, compared with the numbers in wt animals (Fig. 2E) .
Neutrophils from Tg mice express bFcRn and show enhanced IC phagocytosis
We could detect strong bFcRn expression in peritoneal exudate cells and also in neutrophil-enriched cell populations (the average ratio of CD11b/Gr-1 high cells was 96%) from FVB/N_Tg4 mice, by PCR amplification (Fig. 3A) . To test whether the elevated FcRn expression in neutrophils derived from Tg mice influences the phagocytotic activity, we used the neutrophil-enriched cells and analyzed their Alexa-OVA-IgG IC uptake. This test showed a significantly higher number of Alexa-positive cells derived from Tg mice, compared with their wt controls (Fig. 3B, 3C ).
Tg animals showed a superior hapten-specific immune response
The hapten-specific immune response was analyzed by immunizing these mice with TNP-conjugated hIgG. The TNP-specific humoral immune response showed a pattern similar to that observed in the OVA-specific immunization; however, the degree of the difference between Tg and wt mice was much greater (Fig. 4A-C) . The relative affinity of anti-TNP IgG Abs in the sera of wt and FVB/ N_Tg4 animals was estimated by calculating the ratios of Ab bound to sparsely haptenated IgY (TNP 4 -IgY) versus highly haptenated IgY (TNP 42 -IgY). With highly haptenated IgY, we could reveal all TNP-reactive IgGs, whereas we detected Abs with only relatively high affinities for the hapten using ELISA plates coated with the same concentration of IgY carrying only four TNP residues for every IgY. Abs with low affinity manifest higher off rates from TNP 4 -IgY than from TNP 42 -IgY and are not detected using the thinly haptenated carrier molecule (28) . As shown in Fig. 4D , the average TNP 4 /TNP 42 binding ratios indicate that high-affinity Abs are present in the sera of both wt and Tg animals, implying an appropriate affinity maturation in both animal groups. It is also worth mentioning that this technique detects the average avidity of the Ab for the hapten; however, in the case of bivalent IgGs, this measurement closely estimates affinity (25) .
To refine our approach, we used QCM analysis and immobilized TNP 1.5 -IgY at low concentration to minimize the off-rate underestimation caused by the avidity effect. Total IgG samples pooled from FVB/N_Tg4 and wt mice and purified by a protein G column were tested for TNP-specific IgG contents and affinities. We observed very strong average binding characterized by similar on and off rates for both the Tg and the wt IgG samples (Fig. 4E) . Although the average rate constants and, consequently, the equilibrium binding constants for the Tg and wt samples did not differ significantly, we found an ∼3-fold elevation in the concentration of TNP-specific IgG in favor of the Tg animals.
To exclude the possibility that the elevated Ab response is mouse strain dependent, we created bFcRn Tg mice (carrying five copies of This ratio is expressed in percentage. D, Tg mice produced significantly higher amounts of total IgG, compared with wt mice. E, Immunization resulted in an increase in spleen weight and cell numbers. This phenomenon appeared both in wt and in FVB/N_Tg4 mice; however, the spleen size (along with its cell numbers) was doubled in the Tg animals compared with wt controls (p , 0.001). F, ELISPOT assays were performed to test for the presence of OVA-specific B cells. The number of OVA-specific cells was calculated taking into account the total spleen cell number. Multiple-fold increase of OVA-specific IgM and IgG producer cells was detected in the spleens of FVB/N_Tg4 mice compared with wt controls. Significance levels indicate the difference between Tg and wt mice. Values shown are the mean 6 SEM. All experiments were repeated three times with similar results. *p , 0.05; **p , 0.01; ***p , 0.001. the bFcRn) on a BALB/c background and repeated the TNP-hIgG immunization. We found that the BALB/c_Tg5 mice generated a superior humoral immune response similar to that observed in the original FVB/N genetic background. Thus, the bFcRn overexpressionrelated enhancement of the humoral immune response does not show dependence on strain (Supplemental Fig. 2A, 2B ).
Virus-specific antiserum from Tg mice, compared with wt animals, showed doubled activity in virus neutralization assay
To compare the functional activity of Abs derived from Tg and wt mice, an H1N1-like virus strain vaccine (Fluval P) immunization was performed. BALB/c_Tg5 mice, compared with wt, generated doubled Ag-specific ELISA titer and a similarly increased virus neutralization activity (Fig. 5A , 5B). As with our previous OVA and TNP-hIgG immunizations, we observed bigger spleens and more splenocytes in BALB/c_Tg5 animals (data not shown) and a significantly increased number of virus-specific IgM-and IgGproducing B cells than were found in the wt animals (Fig. 5C ).
Immunization with FITC-dextran
We analyzed whether FcRn overexpression influences the T cellindependent humoral immune response by immunizing these animals with a haptenated polysaccharide, FITC-dextran. In determining the hapten-specific IgM and IgG titers by ELISA, the animals showed very similar FITC-specific IgM responses (Fig.  6A) , and although the animals produced a very low level of FITCspecific IgG, it was significantly higher in FVB/N_Tg4 mice than in their controls (Fig. 6B) .
Tg mice have a higher albumin level than do wt animals, but albumin concentration is reduced during the immune response in both groups We also analyzed the albumin level during the immune response, as FcRn regulates the catabolism of this molecule, too. FVB/N_Tg4 mice had significantly higher serum albumin concentration before OVA immunization (at the age of 56 d), when the serum IgG level was low, and also on day 56 of the immune response (at the age of 112 d) (Fig. 7) , when the IgG level was very high (∼33 mg/ml) in Tg mice and normal (∼12 mg/ml) in wt mice (Fig. 1D) . In addition, we observed a marked decrease in the albumin concentration associated with the immunization (Fig. 7) . In conclusion, we found that bFcRn overexpression resulted in an elevated albumin level in nonimmunized animals, which markedly decreased to the level in wt animals at high IgG concentration.
bFcRn integrated into different sites of the host genome in the two Tg mouse lines
To exclude the possibility that the bovine BAC used to create the bFcRn Tg mice (14) accidentally integrated at identical sites of the host genome in both Tg lines, and thus possibly caused the phenotypes of the FVB/N_Tg4 and FVB/N_Tg5 to be the result of insertional mutagenesis of unidentified gene(s) at the transgene integration sites, we performed FISH analysis. We found that the fluorescently labeled BAC hybridized to entirely different chromosome segments in the FVB/N_Tg4 and FVB/N_Tg5 mice strains, respectively. Moreover, the single spots in the chromosomes indicate that the transgene integration most probably occurred in the form of tandem repeats (Fig. 8) . We concluded that the change in the humoral immune response and albumin levels in both of the Tg lines (lines no. 14 and no. 19) were independent of the transgene integration sites.
Discussion
Immunization protocols for the production and subsequent maintenance of high levels of Ag-specific polyclonal Ab require hyperimmunization. Although serum IgG levels may exceed normal levels following immunization, the rate of breakdown is also exponentially increased (2, 13) . Therefore, frequent immunizations are required to maintain high levels of Ag-specific IgG. FcRn is known to be involved in transporting IgGs within and across the cells of diverse origin, and in doing so, they regulate IgG and albumin concentrations and transport throughout the body (7). It is clear that FcRn-mediated recycling is a major contributor to the high endogenous concentrations of these two important plasma proteins, and basic relations between the IgG levels and the fractional catabolic rates have been extensively studied (12, (29) (30) (31) (32) (33) . To stabilize the high IgG level in immunized animals and maximize the potency of hyperimmunization, we decided to overexpress the FcRn and analyze its consequences in the humoral immune response. Increasing the FcRn expression by transgenesis to reduce IgG clearance is yet an unexplored approach for improving hyperimmunization. We and others have recently shown that higher than normal expressional level of FcRn reduced exogenous IgG catabolism (11, 14, 34) .
However, the question of greater interest was whether better protection of IgG in these Tg mice results in increased Ag-specific Ab levels with high specificity following immunization. Using mice carrying extra copies of the bFcRn a-chain, we demonstrated that immunization with OVA, TNP haptenated protein, and an influenza vaccine generated a remarkable difference in the immune response than what was found in wt controls. Further work revealed that these FcRn-mediated effects had no apparent mouse strain dependence (Supplemental Fig. 2, Fig. 5 ) and was not due to insertional mutagenesis of unidentified gene(s) at transgene integration sites (Fig. 8) . In all experiments the Tg animals, compared with their controls, generated multiple-fold higher levels of Ag-specific IgG titers (Figs. 1, 4, and 5, Supplemental Fig. 2) . The peak value of IgG levels in Tg mice was very high in many cases (∼40 mg/ml in OVA immunization), and it was preserved for a relatively long time (Fig. 1D) , suggesting that the high IgG level was well protected by the overexpressed bFcRn. The very high Ag-specific Ab titers in Tg animals forced us to analyze their specificity in comparison with their wt controls. We found that the average affinity of the Ag-specific Abs generated in Tg mice was at least as good as in the wt controls, analyzed by ELISA and QCM studies (Figs. 1C, 4D, 4E) . Importantly, when evaluating the influenza-specific Abs, we found that their functional capability was doubled, compared with that in wt controls (Fig. 5B) .
Analyzing the levels of OVA-specific IgG isotypes, we found a similar pattern of immune response between Tg and wt mice; however, IgG1 was increased much more than the other IgG isotypes (Supplemental Fig. 1) . We have previously shown that mIgG1 is well protected in these Tg mice (14) , suggesting high affinity binding of this isotype to the bFcRn. Because the interaction of the other mIgG isotypes to the bFcRn have not been analyzed so far, we cannot rule out the possibility that the other mIgGs bind less strongly to the receptor, which would explain our finding.
Interestingly, we found that not only the Ag-specific IgG but also the IgM titers were increased during the secondary immune response. Because IgM does not interact with FcRn (7), we concluded that the robust Ag-specific Ab production in these Tg animals was the result of the additive effects of a better IgG protection and an augmented immune response in the lymphoid organs. This assumption was first confirmed by the finding that after immunization the spleens from Tg mice, compared with those in wt controls, were significantly bigger and contained many more cells (Fig. 1E) . In addition, an enhanced expansion of Agspecific B cell clones was found in the spleens of Tg mice (Figs.  1F, 5C ). This was an interesting result, and therefore we analyzed cell populations in the spleen before and after OVA immunization. We found that the spleens of Tg mice contained slightly more B and T cells, but two to three times as many granulocytes, dendritic cells, and plasma cells as their wt controls (Fig. 2) .
The ability of ICs to induce potent humoral immune responses has long been known. A series of early experiments (35-37) demonstrated the activating capacity of these complexes, finding them able to enhance Ab production. More recently, it was demonstrated that in the presence of Ag-IgG, ICs formed in vivo between the Ag and pre-existing Abs from the primary response activate naive B cells, inducing them to respond with accelerated kinetics and increased magnitude (38) . On the basis of these reports, we propose that the elevated Ag-specific IgM and IgG levels during secondary immune response (Figs. 1A, 4A ) resulted from more potent activation of naive and memory B cells in Tg mice. This finding also explains the difference between the Agspecific Ab levels in Tg and those in wt mice, observed during the secondary immune response.
Our data, showing robust neutrophil influx in immunized wt and Tg mice, are analogous to a recent observation that in the presence of Ag-IgG ICs, the main Ag-specific cells recruited in draining lymph nodes were neutrophils (39) . Also shown was that the amount of IC correlated well with the number of neutrophils entering these secondary lymphoid organs (39) . Because Tg mice produced much more Ag-specific IgGs than did the controls, we concluded that the difference in the number of granulocytes we observed in the Tg compared with the wt mice can be explained at least partly by the greater number of ICs formed in Tg animals. The emerging evidences of the important and multifaceted roles of neutrophil granulocytes in potentiating the adaptive immune response in secondary lymphoid organs have been recently reviewed (40) . Because FcRn is expressed in neutrophils and plays an active role in phagocytosis (15), we also analyzed this function in Tg mice and found that bFcRn is expressed in Tg neutrophils and they phagocytose IgG ICs more efficiently than their wt controls (Fig. 3) .
The role of the FcRn in modulating immune response via clonal expansion of B cells was a striking and unexpected finding. Studies have variably reported that IgG responses to antigenic stimuli are reduced (41) (42) (43) or increased (44, 45) in b 2 m-deficient mice that lack functional FcRn. In contrast, impairment of IgG synthesis was not detected in FcRn a-chain knockout animals, and the low serum IgG levels were explained by impaired IgG protection (46) . However, FcRn expression in professional APCs, which have an essential role in humoral immune responses, has been recently described (16, 17, 47, 48) . These studies indicate that the FcRn efficiently increases phagocytosis and recycles monomeric IgGs out of these cells, as well as directs IgG-Ag complexes into the lysosomes (16, 17) . This latter function is further supported by showing that the MHC class II-associated invariant chain, which is generally restricted to APCs, can associate with FcRn and direct it into lysosomes (49) . Taken together, the data therefore indicate FIGURE 5 . bFcRn Tg animals, compared with wt animals, produce more virus-specific polyclonal Ab. BALB/c_Tg5 and wt mice were immunized i.p. with Fluval P vaccine and boosted 21 d later. Animals were sacrificed on day 28, and sera were collected. A, A 2-fold higher anti-virus IgG titer was determined by ELISA from the sera of Tg animals compared with wt controls. B, Sera from Tg animals showed doubled virus neutralization activity compared with wt sera by hemagglutination inhibition assay. C, ELISPOT assays were performed to test for the presence of Fluval P-specific B cells. The number of virus-specific cells was calculated taking into account the total spleen cell number. A significantly higher number of virus-specific IgM-or IgG-producing B cells were detected in Tg animals than in wt animals. Significance levels indicate the difference between the Tg and wt mice. Values shown are the mean 6 SEM. *p , 0.05. that FcRn redirects Ag complexed with IgG into degradative compartments that are associated with the loading of antigenic peptides onto MHC class II molecules within cells (50) . Although we did not determine whether bFcRn is expressed by professional APCs, or whether these cells differ in Ag presentation compared with wt controls, the higher number of dendritic cells in Tg animals compared with wt controls after immunization (Fig. 2D) suggests that these cells are more abundant and active in spleens of Tg mice and certainly contribute to the augmented immune response we observed. Further studies have been initiated in our laboratory to understand this important phenomenon.
Polysaccharides are classified as T cell-independent type 2 Ags, which engage the BCR and thus induce Ag-specific B cell responses. This process is characterized by very low levels of somatic hypermutation and a low frequency of switching to secondary Ig isotypes, resulting in mostly IgM and IgA with little IgG3 (51, 52) . To analyze the immune response of the bFcRn Tg mice, we immunized these animals with FITC-dextran and measured the FITC-specific immune response. As expected, we found predominantly IgM as FITC-specific Ab both in Tg and in wt mice, with no difference during the immune response. We also detected very low amounts of FITC-specific IgG in both groups, although Tg mice showed more of it (Fig. 6) , probably because of a better IgG rescue in these animals.
An interesting aspect of FcRn overexpression is its potential effect on albumin homeostasis (18) . Overexpression of the FcRn for the purpose of generating more Ag-specific IgG may be advantageous; however, it may lead to a harmful hyperosmotic condition, especially if it coincides with higher than normal levels of albumin. Previous studies indicated that high g-globulin values result in hypoalbuminemia (53, 54) . Our data show that bFcRn overexpression significantly raises serum albumin concentration in nonimmunized animals; however the albumin concentration was radically reduced when the IgG level was high in these mice. Similarly, serum albumin concentration in wt animals showed significant but slight reduction after immunization (Fig. 7) . As the binding sites of the FcRn for IgG and albumin are different (55, 56) , we can exclude the possibility that a high IgG level saturates the FcRn, reducing its capability of albumin protection. Consequently, we suggest the possibility that albumin synthesis is reduced in Tg mice at high IgG levels and also to some extent in wt mice, as was indicated earlier (54) . This finding needs to be further analyzed.
As a consequence of these results, we suggest that overexpression of the FcRn not only rescues the Ag-specific IgG at a greater level but also enhances the expansion of Ag-specific B cells and plasma cells in secondary lymphoid organs. Furthermore, although these two effects act synergistically, the relatively moderate enhancement in protecting the IgG in Tg mice (∼30% longer half-life in Tg than in wt mice) we detected earlier (14) and the steep increase of the Ag-specific IgG level in Tg animals found in this study indicate that the enhanced immune response and IgG production exceeds the significance of the IgG rescue, especially when the plasma IgG concentration is relatively low and FcRn transport is far from saturated. We propose that these effects offer major advantages in mAb production when the goal is to generate a high number of Ag-specific B-cell pools from the spleen to form hybridomas. Furthermore, overexpressing the bovine FcRn in humanized mice that generate fully human monoclonals would be an exciting approach. It is well known that the immune response in Tg mice expressing human IgGs is sometimes less robust than that in strains used to generate mouse mAbs, so more immunizations or Ab screens might be required (57) . On the basis of our current observations and previous finding (which showed very strong binding of the bovine FcRn to human IgG) (58), we propose that overexpression of the bovine FcRn potentially improves the immune response of humanized mice. Our current results also indicate that the adaptation of this technology to larger mammals will bring significant rewards of higher polyclonal Ab production.
